InvestorsObserver
×
News Home

Is Vaxart Inc (VXRT) Stock About to Get Hot Wednesday?

Wednesday, November 15, 2023 03:24 PM | InvestorsObserver Analysts

Mentioned in this article

Is Vaxart Inc (VXRT) Stock About to Get Hot Wednesday?

Overall market sentiment has been high on Vaxart Inc (VXRT) stock lately. VXRT receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Vaxart Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VXRT!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With VXRT Stock Today?

Vaxart Inc (VXRT) stock is trading at $0.86 as of 3:24 PM on Wednesday, Nov 15, a gain of $0.09, or 12.1% from the previous closing price of $0.77. The stock has traded between $0.75 and $0.86 so far today. Volume today is more active than usual. So far 1,326,231 shares have traded compared to average volume of 715,245 shares. To screen for more stocks like Vaxart Inc click here.

More About Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Click Here to get the full Stock Report for Vaxart Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App